What is a Patient Information Leaflet and why is it useful?

The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.

Below is a text only representation of the Patient Information Leaflet. The original can be viewed in PDF format using the link above.

The text only version may be available from RNIB in large print, Braille or audio CD. For further information call RNIB Medicine Leaflet Line on 0800 198 5000. The product code(s) for this leaflet is: PL 00426/0009R.

Liquifilm Tears

Package leaflet: Information for the user

LIQUIFILM TEARS®

1.4% w/v, eye drops, solution

Polyvinyl alcohol

Read all of this leaflet carefully because it contains important information for you.

This medicine is available without prescription. However, you still need to use LIQUIFILM TEARS carefully to get the best results from it.

  • Keep this leaflet. You may need to read it again.
  • Ask your pharmacist if you need more information or advice.
  • You must contact a doctor if your symptoms worsen or do not improve after 3 days.
  • If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.

In this leaflet:

  • 1. What LIQUIFILM TEARS is and what it is used for
  • 2. Before you use LIQUIFILM TEARS
  • 3. How to use LIQUIFILM TEARS
  • 4. Possible side effects
  • 5. How to store LIQUIFILM TEARS
  • 6. Further information

1. WHAT LIQUIFILM TEARS IS AND WHAT IT IS USED FOR

LIQUIFILM TEARS is a substitute for tears and contains a lubricant called polyvinyl alcohol. It is an eye drops solution used for the relief of the symptoms of dry eye (such as soreness, burning, irritation or dryness) caused by your eyes not producing enough tears.

2. BEFORE YOU USE LIQUIFILM TEARS

Do NOT use LIQUIFILM TEARS:

  • if you are allergic (hypersensitive) to polyvinyl alcohol or any of the other ingredients of LIQUIFILM TEARS listed in Section 6, “What LIQUIFILM TEARS contains”.
  • while you are wearing soft contact lenses: you must remove them before using LIQUIFILM TEARS eye drops. After using LIQUIFILM TEARS, wait at least 15 minutes before putting your lenses back in. See also in Section 2, “Important information about some of the ingredients of LIQUIFILM TEARS”.

Take special care with LIQUIFILM TEARS:

Stop using LIQUIFILM TEARS and contact your doctor if:

  • you experience long-lasting redness or irritation of the eye, eye pain, changes in vision
  • your condition worsens or has not improved 3 days after having started treatment with LIQUIFILM TEARS.

Using other medicines

Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.

If you have to use any other eye medicine during treatment with LIQUIFILM TEARS: first use the other eye medicine, wait 15 minutes, then use LIQUIFILM TEARS.

Pregnancy and breast-feeding

You can use LIQUIFILM TEARS if you are pregnant and when you are breast-feeding.

Driving and using machines

Your sight may become blurred for a short time just after using LIQUIFILM TEARS. You should not drive or use machines until your sight is clear again.

Important information about some of the ingredients of LIQUIFILM TEARS

If you wear soft contact lenses you must remove them before using LIQUIFILM TEARS eye drops. After using LIQUIFILM TEARS, you have to wait at least 15 minutes before putting your lenses back in.

This is important because one of the ingredients of LIQUIFILM TEARS, called benzalkonium chloride, may cause eye irritation and can change the colour of soft contact lenses.

3. HOW TO USE LIQUIFILM TEARS

If LIQUIFILM TEARS has been recommended for you then use it exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.

The usual dose of LIQUIFILM TEARS is 1 or 2 drops in each eye that needs treatment as often as you feel the need.

Instructions for use

Do not use the bottle if the seal around the cap is broken before you first open it.

Wash your hands before opening the bottle. Tilt your head back and look at the ceiling.

  • 1. Gently pull down the lower eyelid of the eye that needs treatment until there is a small “pocket”.
  • 2. Turn the bottle upside down. Squeeze it to release 1 drop into the “pocket”.
  • 3. Let go of the lower lid, and blink your eyes a few times. For a second drop repeat the steps 2 and 3.
  • 4. Repeat the steps 1 to 3 for the other eye, if it also needs treatment.

If a drop misses your eye, try again.

To help prevent infection, do not let the tip of the bottle touch your eye, the surrounding tissue or anything else. Put the screw-cap back on to close the bottle, straight after you have used it. Once you have opened the bottle, you must not use it longer than 28 days; please see also Section 5, “How to store LIQUIFILM TEARS”.

If you use more LIQUIFILM TEARS than you should

Using more drops of LIQUIFILM TEARS than you should will not cause you any harm.

If you forget to use LIQUIFILM TEARS

If you have missed a dose of LIQUIFILM TEARS continue with your next dose as normal.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

4. POSSIBLE SIDE EFFECTS

Like all medicines, LIQUIFILM TEARS can cause side effects, although not everybody gets them.

Stop using LIQUIFILM TEARS and contact your doctor if:

  • you experience long-lasting redness or irritation of the eye, eye pain, changes in vision
  • your condition worsens or has not improved 3 days after having started treatment with LIQUIFILM TEARS.

If you experience any of the following side effects just after putting in the drops, talk to your doctor if they worry you:

  • eye pain, eye irritation or feeling of burning in the eye, redness of the eyes, an excess of tears, feeling of something in the eye, an allergic reaction in the eye.

The above mentioned side effects are known to occur, but the number of people likely to be affected can vary.

If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.

5. HOW TO STORE LIQUIFILM TEARS

Keep out of the reach and sight of children.

Do not use LIQUIFILM TEARS after the expiry date which is stated on the bottle label and the carton after ‘EXP.’. The expiry date refers to the last day of that month.

Do not store above 25°C. Do not refrigerate or freeze.

You must throw away the bottle 28 days after you first opened it, even if there are still some drops left.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

6. FURTHER INFORMATION

What LIQUIFILM TEARS contains

  • The active ingredient is polyvinyl alcohol 1.4% w/v.
  • The other ingredients are benzalkonium chloride, sodium chloride, sodium phosphate dibasic, sodium phosphate monobasic, edetate disodium, hydrochloric acid or sodium hydroxide (to adjust pH) and purified water.

What LIQUIFILM TEARS looks like and contents of the pack

LIQUIFILM TEARS is a solution in a plastic bottle with a screw-cap. Each bottle contains 15 ml of solution.

Each pack contains 1 bottle.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder:

Allergan Ltd
Marlow International
The Parkway
Marlow
Bucks
SL7 1YL
UK
Tel:01628 494026
Fax:01628 494057
Email:uk_medinfo@allergan.com

Manufacturer:

Allergan Pharmaceuticals Ireland
Castlebar Road
Westport
County Mayo
Ireland

This leaflet was last approved in July 2009.

To listen to or request a copy of this leaflet in Braille, large print or audio please call, free of charge: 0800 198 5000 (UK only).

Please be ready to give the following information: Polyvinyl alcohol 1.4% w/v reference number PL 00426/0009R.

This is a service provided by the Royal National Institute of the Blind.